董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Zhe Zhang Director 47 未披露 未持股 2022-02-28
Nelson Gentiletti Director 60 未披露 未持股 2022-02-28
John Kim Director 54 未披露 未持股 2022-02-28
Sung Yoon Woo Chief Executive Officer and Director 45 未披露 未持股 2022-02-28
Sungwoo Hyung Chief Financial Officer and Director 36 未披露 未持股 2022-02-28
Joong Myung Cho Director 72 未披露 未持股 2022-02-28
Young Min Kim Director 63 未披露 未持股 2022-02-28
Gary Wunderlich Director 51 未披露 未持股 2022-02-28

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Sung Yoon Woo Chief Executive Officer and Director 45 未披露 未持股 2022-02-28
Sungwoo Hyung Chief Financial Officer and Director 36 未披露 未持股 2022-02-28
Sungsik Lee President 45 未披露 未持股 2022-02-28
Gene Young Cho Chief Operating Officer 38 未披露 未持股 2022-02-28

董事简历

中英对照 |  中文 |  英文
Zhe Zhang

Zhe Zhang自2018年8月15日起担任独立董事。自2013年5月以来,张博士一直是香港证券及期货事务监察委员会证监会和中国证监会(CSRC)授权的资产管理公司SIFT Capital的创始合伙人。自2018年3月起,张博士还担任伦敦和牛津资本市场有限公司(一家受英国金融行为管理局(FCA)监管的实体)的合伙人和并购主管。在此之前,2000年1月至2013年4月,他曾任高盛北京办事处执行董事,曾任高盛北京办事处监事会成员,并领导中国国有企业和上市公司的多宗海外收购。他在基金组建、股票投资和投资组合管理方面经验丰富。在进入私营部门之前,张博士在商务部工作了14年,包括担任驻欧洲外交官。他被授权为香港证监会负责资产管理的负责人,并获准执业为中国证券、期货和基金管理专业人员。现任中国牛津奖学金基金董事会成员,每年参与奖学金获得者的遴选工作。张博士拥有中国对外经济贸易大学博士学位,北京大学和牛津大学硕士学位,上海对外贸易学院学士学位。


Zhe Zhang,serves as Alpha Star Acquisition Corporation Chairman and Chief Executive Officer since April 2021. From August 2018 to February 2020, Mr. Zhang served as an independent director of TKK Symphony Acquisition Corporation. Since May 2013, Dr. Zhang has been a Founding Partner of SIFT Capital, an asset manager licensed by the Securities and Futures Commission (SFC) of Hong Kong and China Securities Regulatory Commission (CSRC). Since February 2019, Dr. Zhang has also been the CEO of Still Waters Green Technology Limited, an asset management company based in London, specializing in the development and management of renewable energy and power generation assets. Prior to that, from January 2000 to April 2013, he was an Executive Director at Goldman Sachs Beijing, where he was a member of the Supervisory Board of Goldman's Beijing Office and led multiple overseas acquisitions by Chinese state-owned enterprises and listed companies. He is experienced with fund formation, equity investment and portfolio management. Before entering the private sector, Dr. Zhang had spent 14 years with MOFCOM including as a diplomat stationed in Europe. He is licensed as a Responsible Officer for Asset Management under the SFC of Hong Kong, as well as the licensed to practice as a professional respectively for securities, futures and fund management in China. Dr. Zhang holds a Ph.D. degree from China University of International Business and Economics, Master's degrees from both Peking University (LL.M.) and Oxford University (Magister Juris), and a Bachelor degree from Shanghai Institute of Foreign Trade (B.A.).
Zhe Zhang自2018年8月15日起担任独立董事。自2013年5月以来,张博士一直是香港证券及期货事务监察委员会证监会和中国证监会(CSRC)授权的资产管理公司SIFT Capital的创始合伙人。自2018年3月起,张博士还担任伦敦和牛津资本市场有限公司(一家受英国金融行为管理局(FCA)监管的实体)的合伙人和并购主管。在此之前,2000年1月至2013年4月,他曾任高盛北京办事处执行董事,曾任高盛北京办事处监事会成员,并领导中国国有企业和上市公司的多宗海外收购。他在基金组建、股票投资和投资组合管理方面经验丰富。在进入私营部门之前,张博士在商务部工作了14年,包括担任驻欧洲外交官。他被授权为香港证监会负责资产管理的负责人,并获准执业为中国证券、期货和基金管理专业人员。现任中国牛津奖学金基金董事会成员,每年参与奖学金获得者的遴选工作。张博士拥有中国对外经济贸易大学博士学位,北京大学和牛津大学硕士学位,上海对外贸易学院学士学位。
Zhe Zhang,serves as Alpha Star Acquisition Corporation Chairman and Chief Executive Officer since April 2021. From August 2018 to February 2020, Mr. Zhang served as an independent director of TKK Symphony Acquisition Corporation. Since May 2013, Dr. Zhang has been a Founding Partner of SIFT Capital, an asset manager licensed by the Securities and Futures Commission (SFC) of Hong Kong and China Securities Regulatory Commission (CSRC). Since February 2019, Dr. Zhang has also been the CEO of Still Waters Green Technology Limited, an asset management company based in London, specializing in the development and management of renewable energy and power generation assets. Prior to that, from January 2000 to April 2013, he was an Executive Director at Goldman Sachs Beijing, where he was a member of the Supervisory Board of Goldman's Beijing Office and led multiple overseas acquisitions by Chinese state-owned enterprises and listed companies. He is experienced with fund formation, equity investment and portfolio management. Before entering the private sector, Dr. Zhang had spent 14 years with MOFCOM including as a diplomat stationed in Europe. He is licensed as a Responsible Officer for Asset Management under the SFC of Hong Kong, as well as the licensed to practice as a professional respectively for securities, futures and fund management in China. Dr. Zhang holds a Ph.D. degree from China University of International Business and Economics, Master's degrees from both Peking University (LL.M.) and Oxford University (Magister Juris), and a Bachelor degree from Shanghai Institute of Foreign Trade (B.A.).
Nelson Gentiletti

Nelson Gentiletti是一名注册会计师,自2019年1月1日起担任我们的首席运营和首席财务官。Gentiletti先生拥有财务,会计和战略规划经验,最近于2011年11月至2018年12月担任TransContinental Inc.的首席财务和发展官。Gentiletti先生自2006年起还担任Sportsscene Group,Inc.的董事会成员,自2019年10月起担任Cascades Inc.的董事会成员。Gentiletti先生于1983年在康科迪亚大学(Concordia University)获得商业学士学位,并于1985年在麦吉尔大学(McGill University)获得公共会计研究生文凭。


Nelson Gentiletti will be appointed as a member of Loop Industries, Inc. Board of Directors in connection with this offering. Mr. Gentiletti most recently retired from Loop Industries, Inc. NASDAQ: LOOP, a company dedicated to the sustainable management and recycling of polyethylene terephthalate (PET) plastics and polyester fibers, where he was the Chief Financial and Chief Operating Officer until 2021. Prior to this, Mr. Gentiletti was the Chief Financial and Development Officer of Transcontinental Inc. (TSX: TCL. A, TCL.B), a packaging and printing company, from November 2001 to December 2018; various operation roles from 2005 to 2011 including the Chief Operating Officer (2009-2011) and the Chief Financial Officer (2002-3004) at Transat AT. Inc. (TSX: TRZ), an integrated international tourism company, from August 2002 to September 2011; the Chief Financial Officer at BCE Emergis Inc., a TSX-listed e-commerce information technology company, from April 2001 to July 2002; and the Chief Financial Officer at Unican Security Systems, a TSX-listed company providing mechanical and electronic access control products, from September 1997 to March 2001. Mr. Gentiletti also sits on two public company boards: Cascades Inc. (TSX: CAS) since 2019 and Transcontinental Inc. (TSX: TCL) since 2021. In addition, Mr. Gentiletti is a member of the Advisory Committee at the John Molson School of Business at Concordia University. Mr. Gentiletti is also a Member of the Ordre des comptables professionnels agréés du Québec (Québec CPA Order). Mr. Gentiletti received a Graduate Diploma in Public Accountancy from McGill University and a B.Com degree from Concordia University.
Nelson Gentiletti是一名注册会计师,自2019年1月1日起担任我们的首席运营和首席财务官。Gentiletti先生拥有财务,会计和战略规划经验,最近于2011年11月至2018年12月担任TransContinental Inc.的首席财务和发展官。Gentiletti先生自2006年起还担任Sportsscene Group,Inc.的董事会成员,自2019年10月起担任Cascades Inc.的董事会成员。Gentiletti先生于1983年在康科迪亚大学(Concordia University)获得商业学士学位,并于1985年在麦吉尔大学(McGill University)获得公共会计研究生文凭。
Nelson Gentiletti will be appointed as a member of Loop Industries, Inc. Board of Directors in connection with this offering. Mr. Gentiletti most recently retired from Loop Industries, Inc. NASDAQ: LOOP, a company dedicated to the sustainable management and recycling of polyethylene terephthalate (PET) plastics and polyester fibers, where he was the Chief Financial and Chief Operating Officer until 2021. Prior to this, Mr. Gentiletti was the Chief Financial and Development Officer of Transcontinental Inc. (TSX: TCL. A, TCL.B), a packaging and printing company, from November 2001 to December 2018; various operation roles from 2005 to 2011 including the Chief Operating Officer (2009-2011) and the Chief Financial Officer (2002-3004) at Transat AT. Inc. (TSX: TRZ), an integrated international tourism company, from August 2002 to September 2011; the Chief Financial Officer at BCE Emergis Inc., a TSX-listed e-commerce information technology company, from April 2001 to July 2002; and the Chief Financial Officer at Unican Security Systems, a TSX-listed company providing mechanical and electronic access control products, from September 1997 to March 2001. Mr. Gentiletti also sits on two public company boards: Cascades Inc. (TSX: CAS) since 2019 and Transcontinental Inc. (TSX: TCL) since 2021. In addition, Mr. Gentiletti is a member of the Advisory Committee at the John Molson School of Business at Concordia University. Mr. Gentiletti is also a Member of the Ordre des comptables professionnels agréés du Québec (Québec CPA Order). Mr. Gentiletti received a Graduate Diploma in Public Accountancy from McGill University and a B.Com degree from Concordia University.
John Kim

John Kim ,自2021年3月起,一直担任Cognizant Technology Solutions Corporation的执行副总裁、总法律顾问、首席企业事务官和秘书。此前,他曾担任Cognizant Technology Solutions Corporation的高级副总裁兼全球商业合同副总法律顾问。在2019年加入认知之前,Kim曾于2012年1月至2019年11月在凯捷担任多个高级领导职位,包括大型交易的全球负责人。在凯捷之前,Kim先生曾于2009年7月至2011年6月担任WNS全球服务的美国法律顾问,并于2001年1月至2006年6月在Cendant Travelport Travelport Travel Distribution Services担任多个领导职务,包括总法律顾问和首席合规官。他在哥伦比亚大学获得英国文学学士学位,并在康奈尔大学法学院获得法律学位。


John Kim,Previously, he was Executive Vice President, General Counsel, Chief Corporate Affairs Officer and Secretary, holding this position from March 2021 to February 2024, Before March 2021, he served as Cognizant Technology Solutions Corporation Senior Vice President and Deputy General Counsel, Global Commercial Contracts. Prior to joining Cognizant in 2019, Mr. Kim held a variety of senior leadership roles at Capgemini from January 2012 to November 2019, including Global Head of Big Deals. Prior to Capgemini, Mr. Kim served as U.S. Counsel for WNS Global Services from July 2009 to June 2011 and held a variety of leadership roles at Cendant Travel Distribution Services (now known as Travelport) from January 2001 to June 2006, including General Counsel and Chief Compliance Officer. He holds a bachelor's degree in English literature from Columbia University and obtained his law degree from Cornell Law School.
John Kim ,自2021年3月起,一直担任Cognizant Technology Solutions Corporation的执行副总裁、总法律顾问、首席企业事务官和秘书。此前,他曾担任Cognizant Technology Solutions Corporation的高级副总裁兼全球商业合同副总法律顾问。在2019年加入认知之前,Kim曾于2012年1月至2019年11月在凯捷担任多个高级领导职位,包括大型交易的全球负责人。在凯捷之前,Kim先生曾于2009年7月至2011年6月担任WNS全球服务的美国法律顾问,并于2001年1月至2006年6月在Cendant Travelport Travelport Travel Distribution Services担任多个领导职务,包括总法律顾问和首席合规官。他在哥伦比亚大学获得英国文学学士学位,并在康奈尔大学法学院获得法律学位。
John Kim,Previously, he was Executive Vice President, General Counsel, Chief Corporate Affairs Officer and Secretary, holding this position from March 2021 to February 2024, Before March 2021, he served as Cognizant Technology Solutions Corporation Senior Vice President and Deputy General Counsel, Global Commercial Contracts. Prior to joining Cognizant in 2019, Mr. Kim held a variety of senior leadership roles at Capgemini from January 2012 to November 2019, including Global Head of Big Deals. Prior to Capgemini, Mr. Kim served as U.S. Counsel for WNS Global Services from July 2009 to June 2011 and held a variety of leadership roles at Cendant Travel Distribution Services (now known as Travelport) from January 2001 to June 2006, including General Counsel and Chief Compliance Officer. He holds a bachelor's degree in English literature from Columbia University and obtained his law degree from Cornell Law School.
Sung Yoon Woo

Sung Yoon Woo自成立以来一直是我们的首席执行官和董事会成员。Woo先生是一位投资者,在战略收购,公司资产剥离,资本重组和增长股本方面有着良好的记录和经验。Woo先生是Credian Partners的Founder兼首席执行官,这是一家位于韩国的私人股本公司。在他17年的投资生涯中,吴先生领导了超过40亿美元的交易,并投资了超过30亿美元。创立Credian Partners公司之前,他曾任职Russell Investments公司,在那里他曾建议韩国国家养老金服务公司,该公司是总资产公司、韩国银行和韩国投资公司(主权财富基金)的全球第三大养老基金,以及其他客户的全球投资组合。任职Russell Investments公司之前,他曾担任Mirae Asset Global Investments公司(韩国最大的资产管理基金之一)的私人股本部门的团队主管,在那里他曾领导多种国内和跨境交易。在Mirae Asset Financial Group“;Mirae Asset”;任职期间,吴先生领导以12亿美元收购了Titleist和Footjoy的母公司Acushnet Company,这意味着内部回报率约为12.53。这笔交易不仅在韩国获得了奖项,而且作为一项关键交易,它也为该国私募股权交易的激增铺平了道路,这一点也是值得注意的。任职Mirae Asset公司之前,他曾任职KBKookmin Bank(韩国最大的零售银行)的投资银行部门,在那里他曾领导多个大型韩国企业集团的交易。吴先生在延世大学获得了法学学士学位,并获得了Buphyun奖学金和康奈尔大学的工商管理硕士学位。


Sung Yoon Woo has been our Chief Executive Officer and a member of our Board of Directors since our inception. Mr. Woo is an investor with a strong track record and experience in strategic acquisitions, corporate divestitures, recapitalizations, and growth equity. Mr. Woo is the Founder and CEO of Credian Partners, a private equity firm based in South Korea. During his 17-year investment career, Mr. Woo has led over $4 billion in transactions and invested over $3 billion. Prior to founding Credian Partners, Mr. Woo was at Russell Investments, where he advised the National Pension Service of Korea, the third-largest pension fund in the world by total assets, the Bank of Korea, and Korea Investment Corporation, a sovereign wealth fund, among other clients on their global portfolio. Prior to Russell Investments, Mr. Woo was a team head of the private equity arm of Mirae Asset Global Investments, one of the largest asset management funds in South Korea, where he led various domestic and cross-border transactions. While at Mirae Asset Financial Group “Mirae Asset”, Mr. Woo led the acquisition of Acushnet Company, the parent company of Titleist and FootJoy, for $1.2 billion, representing an internal rate of return of approximately 12.53. Not only has this transaction won awards in South Korea, but it is also notable as a key transaction that helped pave the way for the proliferation of private equity transactions in the country. Prior to Mirae Asset, Mr. Woo was in the investment banking department of KB Kookmin Bank, the largest retail bank in Korea, where he led multiple transactions with large Korean conglomerates. Mr. Woo received his LL.B. from Yonsei University where he was granted the Buphyun Scholarship and M.B.A. from Cornell University.
Sung Yoon Woo自成立以来一直是我们的首席执行官和董事会成员。Woo先生是一位投资者,在战略收购,公司资产剥离,资本重组和增长股本方面有着良好的记录和经验。Woo先生是Credian Partners的Founder兼首席执行官,这是一家位于韩国的私人股本公司。在他17年的投资生涯中,吴先生领导了超过40亿美元的交易,并投资了超过30亿美元。创立Credian Partners公司之前,他曾任职Russell Investments公司,在那里他曾建议韩国国家养老金服务公司,该公司是总资产公司、韩国银行和韩国投资公司(主权财富基金)的全球第三大养老基金,以及其他客户的全球投资组合。任职Russell Investments公司之前,他曾担任Mirae Asset Global Investments公司(韩国最大的资产管理基金之一)的私人股本部门的团队主管,在那里他曾领导多种国内和跨境交易。在Mirae Asset Financial Group“;Mirae Asset”;任职期间,吴先生领导以12亿美元收购了Titleist和Footjoy的母公司Acushnet Company,这意味着内部回报率约为12.53。这笔交易不仅在韩国获得了奖项,而且作为一项关键交易,它也为该国私募股权交易的激增铺平了道路,这一点也是值得注意的。任职Mirae Asset公司之前,他曾任职KBKookmin Bank(韩国最大的零售银行)的投资银行部门,在那里他曾领导多个大型韩国企业集团的交易。吴先生在延世大学获得了法学学士学位,并获得了Buphyun奖学金和康奈尔大学的工商管理硕士学位。
Sung Yoon Woo has been our Chief Executive Officer and a member of our Board of Directors since our inception. Mr. Woo is an investor with a strong track record and experience in strategic acquisitions, corporate divestitures, recapitalizations, and growth equity. Mr. Woo is the Founder and CEO of Credian Partners, a private equity firm based in South Korea. During his 17-year investment career, Mr. Woo has led over $4 billion in transactions and invested over $3 billion. Prior to founding Credian Partners, Mr. Woo was at Russell Investments, where he advised the National Pension Service of Korea, the third-largest pension fund in the world by total assets, the Bank of Korea, and Korea Investment Corporation, a sovereign wealth fund, among other clients on their global portfolio. Prior to Russell Investments, Mr. Woo was a team head of the private equity arm of Mirae Asset Global Investments, one of the largest asset management funds in South Korea, where he led various domestic and cross-border transactions. While at Mirae Asset Financial Group “Mirae Asset”, Mr. Woo led the acquisition of Acushnet Company, the parent company of Titleist and FootJoy, for $1.2 billion, representing an internal rate of return of approximately 12.53. Not only has this transaction won awards in South Korea, but it is also notable as a key transaction that helped pave the way for the proliferation of private equity transactions in the country. Prior to Mirae Asset, Mr. Woo was in the investment banking department of KB Kookmin Bank, the largest retail bank in Korea, where he led multiple transactions with large Korean conglomerates. Mr. Woo received his LL.B. from Yonsei University where he was granted the Buphyun Scholarship and M.B.A. from Cornell University.
Sungwoo Hyung

Sungwoo Hyung自公司成立起担任首席财务官和董事会成员。Hyung先生在可持续发展和技术价值链中拥有丰富的采购,组织和执行复杂交易的经验。最近,Hyung先生在Nomura Greentech(一家可持续技术和基础设施投资银行)工作,负责执行能源转型和清洁技术领域的多个并购交易和发起工作。他执行了多个DE-SPAC交易,是SPAC覆盖团队的一部分,该团队负责完成所有与可持续发展相关的SPAC业务合并和DE-SPAC交易的大约四分之一。任职Nomura Greentech公司之前,他曾任职Deutsche Bank,在那里他曾专注于技术、媒体和电信部门的并购、债务和股权融资的发起和执行。Hyung先生获得了多伦多大学的学士学位和康奈尔大学的工商管理硕士学位。


Sungwoo Hyung has been our Chief Financial Officer and a member of our Board of Directors since our inception. Mr. Hyung has significant experience sourcing, structuring, and executing complex transactions across the sustainability and technology value chain. Most recently, Mr. Hyung was at Nomura Greentech, a sustainable technology and infrastructure investment bank, responsible for executing multiple M&A transactions and origination efforts within the energy transition and clean technology sectors. He executed multiple de-SPAC transactions and was part of the SPAC coverage team that was responsible for completing approximately a quarter of all sustainability-related SPAC business combinations and de-SPAC transactions. Prior to Nomura Greentech, Mr. Hyung was at Deutsche Bank, where he focused on origination and execution of M&A, debt and equity financing across the technology, media, and telecommunications sectors. Mr. Hyung received his B.A. from University of Toronto and M.B.A. from Cornell University.
Sungwoo Hyung自公司成立起担任首席财务官和董事会成员。Hyung先生在可持续发展和技术价值链中拥有丰富的采购,组织和执行复杂交易的经验。最近,Hyung先生在Nomura Greentech(一家可持续技术和基础设施投资银行)工作,负责执行能源转型和清洁技术领域的多个并购交易和发起工作。他执行了多个DE-SPAC交易,是SPAC覆盖团队的一部分,该团队负责完成所有与可持续发展相关的SPAC业务合并和DE-SPAC交易的大约四分之一。任职Nomura Greentech公司之前,他曾任职Deutsche Bank,在那里他曾专注于技术、媒体和电信部门的并购、债务和股权融资的发起和执行。Hyung先生获得了多伦多大学的学士学位和康奈尔大学的工商管理硕士学位。
Sungwoo Hyung has been our Chief Financial Officer and a member of our Board of Directors since our inception. Mr. Hyung has significant experience sourcing, structuring, and executing complex transactions across the sustainability and technology value chain. Most recently, Mr. Hyung was at Nomura Greentech, a sustainable technology and infrastructure investment bank, responsible for executing multiple M&A transactions and origination efforts within the energy transition and clean technology sectors. He executed multiple de-SPAC transactions and was part of the SPAC coverage team that was responsible for completing approximately a quarter of all sustainability-related SPAC business combinations and de-SPAC transactions. Prior to Nomura Greentech, Mr. Hyung was at Deutsche Bank, where he focused on origination and execution of M&A, debt and equity financing across the technology, media, and telecommunications sectors. Mr. Hyung received his B.A. from University of Toronto and M.B.A. from Cornell University.
Joong Myung Cho

Joong Myung Cho将被任命为本次发行的董事会成员。Young Myung Cho博士是CrystalGenomics的Founder兼董事长兼首席执行官,在生物制药行业拥有超过35年的经验,从研发到新型药物的商业化,是全球领先的生命科学专家。Cho博士此前曾担任LG Life Sciences(前身为LG Chem)的高级执行副总裁兼研发生物技术研究所主任。在他任职期间,LG的生物制药研究所成为世界领先的生命科学公司之一,从仅有的几名研究科学家发展到数百名员工。他成功地推出了10种不同的重组产品,如人、牛、猪的生长激素,乙型肝炎疫苗,干扰素α和γ,粒细胞巨噬细胞集落刺激因子和肌萎缩症,促红细胞生成素等。此外,在他的监督下,有四种候选药物被授权给跨国制药公司,其中一种获得了美国食品药品监督管理局的批准。在这些成就的基础上,Cho博士获得了许多奖项,并担任多个政府委员会的成员。Cho博士在休斯敦大学获得博士学位,并在贝勒医学院担任博士后研究员。Cho博士是80多种出版物的作者,包括《自然》杂志的封面出版物,并拥有200多项申请专利。Joong Myung Cho博士是我们首席运营官Gene Young Cho博士的父亲。


Joong Myung Cho will be appointed as a member of our Board of Directors in connection with this offering. Dr. Young Myung Cho is the Founder, Chairman and Chief Executive Officer of CrystalGenomics and has over 35 years of experience in the biopharmaceuticals industry from R&D to commercialization of novel drugs and is a global leading life sciences expert. Dr. Cho has previously served as the Executive Senior Vice President and Director of R&D Biotech Research Institute at LG Life Sciences formerly LG Chem. During his tenure, the biopharmaceutical institute at LG became one of the leading life science companies in the world, growing from just a few research scientists to several hundred employees. He has successfully introduced 10 different recombinant products such as growth hormones of human, bovine, and porcine, hepatitis B vaccine, interferon alpha and gamma, granulocyte-macrophage colony-stimulating factor and sargramostim, erythropoietin, among others. Moreover, four drug candidates were out-licensed to multinational pharmaceutical companies under his supervision, with one gaining approval from the U.S. Food and Drug Administration (FDA). On the basis of such achievements, Dr. Cho has received many awards and acted as a member of several government committees. Dr. Cho received his Ph.D. from the University of Houston and worked as a post-doctorate fellow at the Baylor College of Medicine. Dr. Cho is an author of more than 80 publications, including a cover-page publication in Nature magazine, and has more than 200 filed patents. Dr. Joong Myung Cho is the father of our Chief Operating Officer, Dr. Gene Young Cho.
Joong Myung Cho将被任命为本次发行的董事会成员。Young Myung Cho博士是CrystalGenomics的Founder兼董事长兼首席执行官,在生物制药行业拥有超过35年的经验,从研发到新型药物的商业化,是全球领先的生命科学专家。Cho博士此前曾担任LG Life Sciences(前身为LG Chem)的高级执行副总裁兼研发生物技术研究所主任。在他任职期间,LG的生物制药研究所成为世界领先的生命科学公司之一,从仅有的几名研究科学家发展到数百名员工。他成功地推出了10种不同的重组产品,如人、牛、猪的生长激素,乙型肝炎疫苗,干扰素α和γ,粒细胞巨噬细胞集落刺激因子和肌萎缩症,促红细胞生成素等。此外,在他的监督下,有四种候选药物被授权给跨国制药公司,其中一种获得了美国食品药品监督管理局的批准。在这些成就的基础上,Cho博士获得了许多奖项,并担任多个政府委员会的成员。Cho博士在休斯敦大学获得博士学位,并在贝勒医学院担任博士后研究员。Cho博士是80多种出版物的作者,包括《自然》杂志的封面出版物,并拥有200多项申请专利。Joong Myung Cho博士是我们首席运营官Gene Young Cho博士的父亲。
Joong Myung Cho will be appointed as a member of our Board of Directors in connection with this offering. Dr. Young Myung Cho is the Founder, Chairman and Chief Executive Officer of CrystalGenomics and has over 35 years of experience in the biopharmaceuticals industry from R&D to commercialization of novel drugs and is a global leading life sciences expert. Dr. Cho has previously served as the Executive Senior Vice President and Director of R&D Biotech Research Institute at LG Life Sciences formerly LG Chem. During his tenure, the biopharmaceutical institute at LG became one of the leading life science companies in the world, growing from just a few research scientists to several hundred employees. He has successfully introduced 10 different recombinant products such as growth hormones of human, bovine, and porcine, hepatitis B vaccine, interferon alpha and gamma, granulocyte-macrophage colony-stimulating factor and sargramostim, erythropoietin, among others. Moreover, four drug candidates were out-licensed to multinational pharmaceutical companies under his supervision, with one gaining approval from the U.S. Food and Drug Administration (FDA). On the basis of such achievements, Dr. Cho has received many awards and acted as a member of several government committees. Dr. Cho received his Ph.D. from the University of Houston and worked as a post-doctorate fellow at the Baylor College of Medicine. Dr. Cho is an author of more than 80 publications, including a cover-page publication in Nature magazine, and has more than 200 filed patents. Dr. Joong Myung Cho is the father of our Chief Operating Officer, Dr. Gene Young Cho.
Young Min Kim

Young Min KIM将被任命为本次发行的董事会成员。KIM先生在韩国政府担任多个高级职位超过35年。2015年至2018年,KIM先生担任韩国资源公司的首席执行官,该公司是一家国有能源和自然资源公司,致力于海外资源开发,为韩国行业提供战略性矿产。在领导KORES之前,KIM先生是韩国知识产权局的专员,专利和知识产权局负责处理和传播与韩国专利申请,商标申请和设计申请有关的信息。此前,KIM先生在韩国贸易、工业和能源部担任多个执行职位,包括中小企业和创业政策、外国投资支持和贸易合作政策。KIM先生在Kyungpook National University获得公共管理学士学位,在University of Wisconsin-Madison获得政治学硕士学位。


Young Min Kim will be appointed as a member of our Board of Directors in connection with this offering. Mr. Kim served in various high-ranking positions for the government of South Korea for over 35 years. Between 2015 and 2018 Mr. Kim was the CEO of Korea Resources Corporation “KORES”, a government-owned energy and natural resources company dedicated to overseas resources development to provide strategic minerals to the Korean industry. Prior to leading KORES, Mr. Kim was the Commissioner of the Korean Intellectual Property Office, the patent and intellectual property office responsible for processing and disseminating information relating to South Korean patent applications, trademark applications, and design applications. Previously, Mr. Kim held multiple executive roles at the Ministry of Trade, Industry and Energy of South Korea, including SME and startup policy, foreign investment support, and trade cooperation policy. Mr. Kim received a B.A. in Public Administration from Kyungpook National University and an M.A. in Political Science from University of Wisconsin-Madison.
Young Min KIM将被任命为本次发行的董事会成员。KIM先生在韩国政府担任多个高级职位超过35年。2015年至2018年,KIM先生担任韩国资源公司的首席执行官,该公司是一家国有能源和自然资源公司,致力于海外资源开发,为韩国行业提供战略性矿产。在领导KORES之前,KIM先生是韩国知识产权局的专员,专利和知识产权局负责处理和传播与韩国专利申请,商标申请和设计申请有关的信息。此前,KIM先生在韩国贸易、工业和能源部担任多个执行职位,包括中小企业和创业政策、外国投资支持和贸易合作政策。KIM先生在Kyungpook National University获得公共管理学士学位,在University of Wisconsin-Madison获得政治学硕士学位。
Young Min Kim will be appointed as a member of our Board of Directors in connection with this offering. Mr. Kim served in various high-ranking positions for the government of South Korea for over 35 years. Between 2015 and 2018 Mr. Kim was the CEO of Korea Resources Corporation “KORES”, a government-owned energy and natural resources company dedicated to overseas resources development to provide strategic minerals to the Korean industry. Prior to leading KORES, Mr. Kim was the Commissioner of the Korean Intellectual Property Office, the patent and intellectual property office responsible for processing and disseminating information relating to South Korean patent applications, trademark applications, and design applications. Previously, Mr. Kim held multiple executive roles at the Ministry of Trade, Industry and Energy of South Korea, including SME and startup policy, foreign investment support, and trade cooperation policy. Mr. Kim received a B.A. in Public Administration from Kyungpook National University and an M.A. in Political Science from University of Wisconsin-Madison.
Gary Wunderlich

Gary Wunderlich将被任命为与本次发行有关的董事会成员。Wunderlich先生是Live OakMerchant Partners的联席Founder兼管理合伙人,这是一家商业银行,为众多行业的中间市场公司提供资本和咨询服务。2020年1月至2020年12月,Wunderlich先生担任Live Oak Acquisition Corp.的总裁兼首席财务官。纽约证券交易所:Loak,于2020年12月29日完成了与Meredian Holdings Group,Inc.的业务合并,该公司是一家佐治亚州公司,由Danimer Scientific(纽约证券交易所代码:DNMR)组成。从2020年8月至2021年10月,Wunderlich先生还担任Live Oak Acquisition Corp.的总裁兼首席财务官。是Navitas Semiconductors(纳斯达克市场代码:NVTS)的董事,该公司完成了与Live Oak Acquisition Corp.的业务合并2021年10月20日。自2021年1月以来,Wunderlich先生一直担任Live Oak Mobility Acquisition Corp.(纽约证券交易所代码:LOKM)和Live OakCrestview Climate Acquisition Corp(纽约证券交易所代码:LOCC)空白支票公司的总裁兼首席财务官,这两家公司分别于2021年3月完成了253000000美元的首次公开发行,并于2021年10月完成了2000000000美元的首次公开发行。Live Oak Mobility Acquisition Corp.和Live OakCrestview Climate Acquisition Corp目前正在寻求完成一项初步的业务合并。在共同创立Live OakMerchant Partners之前,Wunderlich先生是Wunderlich Securities,Inc.的Founder兼首席执行官,这是一家提供全方位服务的投资银行和经纪公司。在他的领导下,Wunderlich Securities,Inc.从一家虚拟的初创公司发展成为一家提供全方位服务的投资银行公司,拥有400多名员工,管理的客户资产超过100亿美元。2017年,Wunderlich先生帮助领导Wunderlich Securities,Inc.与B. Riley Financial, Inc.(纳斯达克市场代码:RILY)的合并。合并后,Wunderlich先生担任B. Riley Financial, Inc.的董事和Wunderlich Securities,Inc.(更名为B.Riley Wealth)的首席执行官,直到2018年11月。Wunderlich先生在整个职业生涯中也一直参与证券行业组织。2016年至2018年,Wunderlich先生是证券业和金融市场协会(“;SIFMA”;)国家董事会的成员。从2016年美国证券协会成立到2018年,他还是该协会的创始董事会成员。Wunderlich先生还在金融业监管局担任过各种职务,包括在国家咨询委员会任职,在第5区委员会担任成员和主席,并担任国家会员委员会成员。自2020年3月以来,Wunderlich先生一直担任医疗设备供应商America’s Lift Chair,LLC的董事会成员。自2005年以来,Wunderlich先生一直是Young Presidents’Organization的成员,并参与家族企业,家族办公室,金融服务和创业与创新网络。他于2014年加入企业家协会,自2016年以来一直担任董事。他也是Eighty Park Avenue Partners LLC(一个家庭投资工具)的管理成员。Wunderlich先生在弗吉尼亚大学获得经济学学士学位,并在孟菲斯大学获得工商管理硕士学位。


Gary Wunderlich will be appointed as a member of our Board of Directors in connection with this offering. Mr. Wunderlich is a Co-Founder and Managing Partner of Live Oak Merchant Partners, a merchant bank providing capital and advisory services to middle market companies across a wide range of industries. From January 2020 to December 2020 Mr. Wunderlich served as the President and the Chief Financial Officer of Live Oak Acquisition Corp. NYSE: LOAK, which completed its business combination with Meredian Holdings Group, Inc., a Georgia corporation d/b/a Danimer Scientific (NYSE: DNMR) on December 29 2020. From August 2020 to October 2021 Mr. Wunderlich also served as the President and the Chief Financial Officer of Live Oak Acquisition Corp. II (NYSE: LOKB) and is a director of Navitas Semiconductors (NASDAQ: NVTS), which completed its business combination with Live Oak Acquisition Corp. II on October 20 2021. Since January 2021 Mr. Wunderlich has served as President and Chief Financial Officer of Live Oak Mobility Acquisition Corp. (NYSE: LOKM) and Live Oak Crestview Climate Acquisition Corp (NYSE: LOCC) blank check companies, which consummated their initial public offerings of $253000000 in March 2021 and $200000000 in October 2021 respectively. Live Oak Mobility Acquisition Corp. and Live Oak Crestview Climate Acquisition Corp are currently seeking to consummate an initial business combination. Prior to co-founding Live Oak Merchant Partners, Mr. Wunderlich was the founder and CEO of Wunderlich Securities, Inc., a full-service investment banking and brokerage firm. Under his leadership Wunderlich Securities, Inc. grew from a virtual start-up into a full-service investment banking firm with over 400 employees and over $10 billion of client assets under management. In 2017 Mr. Wunderlich helped lead the merger of Wunderlich Securities, Inc. into B. Riley Financial, Inc. (NASDAQ: RILY). Following the merger, Mr. Wunderlich served as a director of B. Riley Financial, Inc. and as CEO of Wunderlich Securities, Inc. (rebranded B. Riley Wealth) until November 2018. Mr. Wunderlich has also been consistently involved in securities industry organizations throughout his career. From 2016 to 2018 Mr. Wunderlich was a member of the Securities Industry and Financial Markets Association's (“SIFMA”) National Board of Directors. He was also a founding board member of the American Securities Association from its inception in 2016 until 2018. Mr. Wunderlich also served in various capacities with the Financial Industry Regulatory Authority (FINRA) including serving on the National Advisory Board, serving on the District 5 Committee as both a Member and Chairman, and serving as a Member of the National Membership Council. Since March 2020 Mr. Wunderlich has served as a board member of America's Lift Chair, LLC, a medical equipment supplier. Since 2005 Mr. Wunderlich has been a member of the Young Presidents' Organization and participates in the Family Business, Family Office, Financial Services and Entrepreneurship and Innovation Networks. He was inducted into the Society of Entrepreneurs in 2014 and has served as a Director since 2016. He is also the Managing Member of Eighty Park Avenue Partners LLC, a family investment vehicle. Mr. Wunderlich received a B.A.in Economics from the University of Virginia and an M.B.A. from the University of Memphis.
Gary Wunderlich将被任命为与本次发行有关的董事会成员。Wunderlich先生是Live OakMerchant Partners的联席Founder兼管理合伙人,这是一家商业银行,为众多行业的中间市场公司提供资本和咨询服务。2020年1月至2020年12月,Wunderlich先生担任Live Oak Acquisition Corp.的总裁兼首席财务官。纽约证券交易所:Loak,于2020年12月29日完成了与Meredian Holdings Group,Inc.的业务合并,该公司是一家佐治亚州公司,由Danimer Scientific(纽约证券交易所代码:DNMR)组成。从2020年8月至2021年10月,Wunderlich先生还担任Live Oak Acquisition Corp.的总裁兼首席财务官。是Navitas Semiconductors(纳斯达克市场代码:NVTS)的董事,该公司完成了与Live Oak Acquisition Corp.的业务合并2021年10月20日。自2021年1月以来,Wunderlich先生一直担任Live Oak Mobility Acquisition Corp.(纽约证券交易所代码:LOKM)和Live OakCrestview Climate Acquisition Corp(纽约证券交易所代码:LOCC)空白支票公司的总裁兼首席财务官,这两家公司分别于2021年3月完成了253000000美元的首次公开发行,并于2021年10月完成了2000000000美元的首次公开发行。Live Oak Mobility Acquisition Corp.和Live OakCrestview Climate Acquisition Corp目前正在寻求完成一项初步的业务合并。在共同创立Live OakMerchant Partners之前,Wunderlich先生是Wunderlich Securities,Inc.的Founder兼首席执行官,这是一家提供全方位服务的投资银行和经纪公司。在他的领导下,Wunderlich Securities,Inc.从一家虚拟的初创公司发展成为一家提供全方位服务的投资银行公司,拥有400多名员工,管理的客户资产超过100亿美元。2017年,Wunderlich先生帮助领导Wunderlich Securities,Inc.与B. Riley Financial, Inc.(纳斯达克市场代码:RILY)的合并。合并后,Wunderlich先生担任B. Riley Financial, Inc.的董事和Wunderlich Securities,Inc.(更名为B.Riley Wealth)的首席执行官,直到2018年11月。Wunderlich先生在整个职业生涯中也一直参与证券行业组织。2016年至2018年,Wunderlich先生是证券业和金融市场协会(“;SIFMA”;)国家董事会的成员。从2016年美国证券协会成立到2018年,他还是该协会的创始董事会成员。Wunderlich先生还在金融业监管局担任过各种职务,包括在国家咨询委员会任职,在第5区委员会担任成员和主席,并担任国家会员委员会成员。自2020年3月以来,Wunderlich先生一直担任医疗设备供应商America’s Lift Chair,LLC的董事会成员。自2005年以来,Wunderlich先生一直是Young Presidents’Organization的成员,并参与家族企业,家族办公室,金融服务和创业与创新网络。他于2014年加入企业家协会,自2016年以来一直担任董事。他也是Eighty Park Avenue Partners LLC(一个家庭投资工具)的管理成员。Wunderlich先生在弗吉尼亚大学获得经济学学士学位,并在孟菲斯大学获得工商管理硕士学位。
Gary Wunderlich will be appointed as a member of our Board of Directors in connection with this offering. Mr. Wunderlich is a Co-Founder and Managing Partner of Live Oak Merchant Partners, a merchant bank providing capital and advisory services to middle market companies across a wide range of industries. From January 2020 to December 2020 Mr. Wunderlich served as the President and the Chief Financial Officer of Live Oak Acquisition Corp. NYSE: LOAK, which completed its business combination with Meredian Holdings Group, Inc., a Georgia corporation d/b/a Danimer Scientific (NYSE: DNMR) on December 29 2020. From August 2020 to October 2021 Mr. Wunderlich also served as the President and the Chief Financial Officer of Live Oak Acquisition Corp. II (NYSE: LOKB) and is a director of Navitas Semiconductors (NASDAQ: NVTS), which completed its business combination with Live Oak Acquisition Corp. II on October 20 2021. Since January 2021 Mr. Wunderlich has served as President and Chief Financial Officer of Live Oak Mobility Acquisition Corp. (NYSE: LOKM) and Live Oak Crestview Climate Acquisition Corp (NYSE: LOCC) blank check companies, which consummated their initial public offerings of $253000000 in March 2021 and $200000000 in October 2021 respectively. Live Oak Mobility Acquisition Corp. and Live Oak Crestview Climate Acquisition Corp are currently seeking to consummate an initial business combination. Prior to co-founding Live Oak Merchant Partners, Mr. Wunderlich was the founder and CEO of Wunderlich Securities, Inc., a full-service investment banking and brokerage firm. Under his leadership Wunderlich Securities, Inc. grew from a virtual start-up into a full-service investment banking firm with over 400 employees and over $10 billion of client assets under management. In 2017 Mr. Wunderlich helped lead the merger of Wunderlich Securities, Inc. into B. Riley Financial, Inc. (NASDAQ: RILY). Following the merger, Mr. Wunderlich served as a director of B. Riley Financial, Inc. and as CEO of Wunderlich Securities, Inc. (rebranded B. Riley Wealth) until November 2018. Mr. Wunderlich has also been consistently involved in securities industry organizations throughout his career. From 2016 to 2018 Mr. Wunderlich was a member of the Securities Industry and Financial Markets Association's (“SIFMA”) National Board of Directors. He was also a founding board member of the American Securities Association from its inception in 2016 until 2018. Mr. Wunderlich also served in various capacities with the Financial Industry Regulatory Authority (FINRA) including serving on the National Advisory Board, serving on the District 5 Committee as both a Member and Chairman, and serving as a Member of the National Membership Council. Since March 2020 Mr. Wunderlich has served as a board member of America's Lift Chair, LLC, a medical equipment supplier. Since 2005 Mr. Wunderlich has been a member of the Young Presidents' Organization and participates in the Family Business, Family Office, Financial Services and Entrepreneurship and Innovation Networks. He was inducted into the Society of Entrepreneurs in 2014 and has served as a Director since 2016. He is also the Managing Member of Eighty Park Avenue Partners LLC, a family investment vehicle. Mr. Wunderlich received a B.A.in Economics from the University of Virginia and an M.B.A. from the University of Memphis.

高管简历

中英对照 |  中文 |  英文
Sung Yoon Woo

Sung Yoon Woo自成立以来一直是我们的首席执行官和董事会成员。Woo先生是一位投资者,在战略收购,公司资产剥离,资本重组和增长股本方面有着良好的记录和经验。Woo先生是Credian Partners的Founder兼首席执行官,这是一家位于韩国的私人股本公司。在他17年的投资生涯中,吴先生领导了超过40亿美元的交易,并投资了超过30亿美元。创立Credian Partners公司之前,他曾任职Russell Investments公司,在那里他曾建议韩国国家养老金服务公司,该公司是总资产公司、韩国银行和韩国投资公司(主权财富基金)的全球第三大养老基金,以及其他客户的全球投资组合。任职Russell Investments公司之前,他曾担任Mirae Asset Global Investments公司(韩国最大的资产管理基金之一)的私人股本部门的团队主管,在那里他曾领导多种国内和跨境交易。在Mirae Asset Financial Group“;Mirae Asset”;任职期间,吴先生领导以12亿美元收购了Titleist和Footjoy的母公司Acushnet Company,这意味着内部回报率约为12.53。这笔交易不仅在韩国获得了奖项,而且作为一项关键交易,它也为该国私募股权交易的激增铺平了道路,这一点也是值得注意的。任职Mirae Asset公司之前,他曾任职KBKookmin Bank(韩国最大的零售银行)的投资银行部门,在那里他曾领导多个大型韩国企业集团的交易。吴先生在延世大学获得了法学学士学位,并获得了Buphyun奖学金和康奈尔大学的工商管理硕士学位。


Sung Yoon Woo has been our Chief Executive Officer and a member of our Board of Directors since our inception. Mr. Woo is an investor with a strong track record and experience in strategic acquisitions, corporate divestitures, recapitalizations, and growth equity. Mr. Woo is the Founder and CEO of Credian Partners, a private equity firm based in South Korea. During his 17-year investment career, Mr. Woo has led over $4 billion in transactions and invested over $3 billion. Prior to founding Credian Partners, Mr. Woo was at Russell Investments, where he advised the National Pension Service of Korea, the third-largest pension fund in the world by total assets, the Bank of Korea, and Korea Investment Corporation, a sovereign wealth fund, among other clients on their global portfolio. Prior to Russell Investments, Mr. Woo was a team head of the private equity arm of Mirae Asset Global Investments, one of the largest asset management funds in South Korea, where he led various domestic and cross-border transactions. While at Mirae Asset Financial Group “Mirae Asset”, Mr. Woo led the acquisition of Acushnet Company, the parent company of Titleist and FootJoy, for $1.2 billion, representing an internal rate of return of approximately 12.53. Not only has this transaction won awards in South Korea, but it is also notable as a key transaction that helped pave the way for the proliferation of private equity transactions in the country. Prior to Mirae Asset, Mr. Woo was in the investment banking department of KB Kookmin Bank, the largest retail bank in Korea, where he led multiple transactions with large Korean conglomerates. Mr. Woo received his LL.B. from Yonsei University where he was granted the Buphyun Scholarship and M.B.A. from Cornell University.
Sung Yoon Woo自成立以来一直是我们的首席执行官和董事会成员。Woo先生是一位投资者,在战略收购,公司资产剥离,资本重组和增长股本方面有着良好的记录和经验。Woo先生是Credian Partners的Founder兼首席执行官,这是一家位于韩国的私人股本公司。在他17年的投资生涯中,吴先生领导了超过40亿美元的交易,并投资了超过30亿美元。创立Credian Partners公司之前,他曾任职Russell Investments公司,在那里他曾建议韩国国家养老金服务公司,该公司是总资产公司、韩国银行和韩国投资公司(主权财富基金)的全球第三大养老基金,以及其他客户的全球投资组合。任职Russell Investments公司之前,他曾担任Mirae Asset Global Investments公司(韩国最大的资产管理基金之一)的私人股本部门的团队主管,在那里他曾领导多种国内和跨境交易。在Mirae Asset Financial Group“;Mirae Asset”;任职期间,吴先生领导以12亿美元收购了Titleist和Footjoy的母公司Acushnet Company,这意味着内部回报率约为12.53。这笔交易不仅在韩国获得了奖项,而且作为一项关键交易,它也为该国私募股权交易的激增铺平了道路,这一点也是值得注意的。任职Mirae Asset公司之前,他曾任职KBKookmin Bank(韩国最大的零售银行)的投资银行部门,在那里他曾领导多个大型韩国企业集团的交易。吴先生在延世大学获得了法学学士学位,并获得了Buphyun奖学金和康奈尔大学的工商管理硕士学位。
Sung Yoon Woo has been our Chief Executive Officer and a member of our Board of Directors since our inception. Mr. Woo is an investor with a strong track record and experience in strategic acquisitions, corporate divestitures, recapitalizations, and growth equity. Mr. Woo is the Founder and CEO of Credian Partners, a private equity firm based in South Korea. During his 17-year investment career, Mr. Woo has led over $4 billion in transactions and invested over $3 billion. Prior to founding Credian Partners, Mr. Woo was at Russell Investments, where he advised the National Pension Service of Korea, the third-largest pension fund in the world by total assets, the Bank of Korea, and Korea Investment Corporation, a sovereign wealth fund, among other clients on their global portfolio. Prior to Russell Investments, Mr. Woo was a team head of the private equity arm of Mirae Asset Global Investments, one of the largest asset management funds in South Korea, where he led various domestic and cross-border transactions. While at Mirae Asset Financial Group “Mirae Asset”, Mr. Woo led the acquisition of Acushnet Company, the parent company of Titleist and FootJoy, for $1.2 billion, representing an internal rate of return of approximately 12.53. Not only has this transaction won awards in South Korea, but it is also notable as a key transaction that helped pave the way for the proliferation of private equity transactions in the country. Prior to Mirae Asset, Mr. Woo was in the investment banking department of KB Kookmin Bank, the largest retail bank in Korea, where he led multiple transactions with large Korean conglomerates. Mr. Woo received his LL.B. from Yonsei University where he was granted the Buphyun Scholarship and M.B.A. from Cornell University.
Sungwoo Hyung

Sungwoo Hyung自公司成立起担任首席财务官和董事会成员。Hyung先生在可持续发展和技术价值链中拥有丰富的采购,组织和执行复杂交易的经验。最近,Hyung先生在Nomura Greentech(一家可持续技术和基础设施投资银行)工作,负责执行能源转型和清洁技术领域的多个并购交易和发起工作。他执行了多个DE-SPAC交易,是SPAC覆盖团队的一部分,该团队负责完成所有与可持续发展相关的SPAC业务合并和DE-SPAC交易的大约四分之一。任职Nomura Greentech公司之前,他曾任职Deutsche Bank,在那里他曾专注于技术、媒体和电信部门的并购、债务和股权融资的发起和执行。Hyung先生获得了多伦多大学的学士学位和康奈尔大学的工商管理硕士学位。


Sungwoo Hyung has been our Chief Financial Officer and a member of our Board of Directors since our inception. Mr. Hyung has significant experience sourcing, structuring, and executing complex transactions across the sustainability and technology value chain. Most recently, Mr. Hyung was at Nomura Greentech, a sustainable technology and infrastructure investment bank, responsible for executing multiple M&A transactions and origination efforts within the energy transition and clean technology sectors. He executed multiple de-SPAC transactions and was part of the SPAC coverage team that was responsible for completing approximately a quarter of all sustainability-related SPAC business combinations and de-SPAC transactions. Prior to Nomura Greentech, Mr. Hyung was at Deutsche Bank, where he focused on origination and execution of M&A, debt and equity financing across the technology, media, and telecommunications sectors. Mr. Hyung received his B.A. from University of Toronto and M.B.A. from Cornell University.
Sungwoo Hyung自公司成立起担任首席财务官和董事会成员。Hyung先生在可持续发展和技术价值链中拥有丰富的采购,组织和执行复杂交易的经验。最近,Hyung先生在Nomura Greentech(一家可持续技术和基础设施投资银行)工作,负责执行能源转型和清洁技术领域的多个并购交易和发起工作。他执行了多个DE-SPAC交易,是SPAC覆盖团队的一部分,该团队负责完成所有与可持续发展相关的SPAC业务合并和DE-SPAC交易的大约四分之一。任职Nomura Greentech公司之前,他曾任职Deutsche Bank,在那里他曾专注于技术、媒体和电信部门的并购、债务和股权融资的发起和执行。Hyung先生获得了多伦多大学的学士学位和康奈尔大学的工商管理硕士学位。
Sungwoo Hyung has been our Chief Financial Officer and a member of our Board of Directors since our inception. Mr. Hyung has significant experience sourcing, structuring, and executing complex transactions across the sustainability and technology value chain. Most recently, Mr. Hyung was at Nomura Greentech, a sustainable technology and infrastructure investment bank, responsible for executing multiple M&A transactions and origination efforts within the energy transition and clean technology sectors. He executed multiple de-SPAC transactions and was part of the SPAC coverage team that was responsible for completing approximately a quarter of all sustainability-related SPAC business combinations and de-SPAC transactions. Prior to Nomura Greentech, Mr. Hyung was at Deutsche Bank, where he focused on origination and execution of M&A, debt and equity financing across the technology, media, and telecommunications sectors. Mr. Hyung received his B.A. from University of Toronto and M.B.A. from Cornell University.
Sungsik Lee

Sungsik Lee自成立以来一直担任我们的总裁。Lee先生在投资银行,风险资本和企业发展方面拥有丰富的经验,在采购和执行并购,战略投资和融资交易方面有着良好的记录。最近,Lee先生在SK的全球发展集团领导跨境并购和战略投资,该集团是韩国第三大企业集团,在能源,ICT和生命科学等多个行业拥有100多家分支机构。任职SK公司之前,他曾任职SunTrust Robinson Humphrey公司,在那里他曾建议许多上市工业公司的并购和资本市场交易。加入SunTrust之前,他曾任职Progress Partners公司(专注于媒体和技术的投资银行公司),在那里他曾为早期到中期阶段的客户执行并购和融资项目,并管理Progress Ventures公司(其附属风险资本部门)的三个投资基金。李先生在汉阳大学获得学士学位,在康奈尔大学获得工商管理硕士学位。


Sungsik Lee has been our President since our inception. Most recently, Mr. Lee led cross-border M&A and strategic investments across the broad sustainability-focused areas at the Global Development Group of SK, the third-largest conglomerate in Korea with more than 100 affiliates over diverse sectors including energy, ICT, and life sciences. Prior to SK, Mr. Lee was at SunTrust Robinson Humphrey, where he advised many publicly traded industrial companies on M&A and capital market transactions. Before joining SunTrust, Mr. Lee was at Progress Partners, a media and technology-focused investment banking firm, where he executed M&A and financing projects for early-to-mid-stage clients and managed three investment funds at Progress Ventures, its affiliated venture capital arm. Mr. Lee received his B.A. from Hanyang University and M.B.A. from Cornell University.
Sungsik Lee自成立以来一直担任我们的总裁。Lee先生在投资银行,风险资本和企业发展方面拥有丰富的经验,在采购和执行并购,战略投资和融资交易方面有着良好的记录。最近,Lee先生在SK的全球发展集团领导跨境并购和战略投资,该集团是韩国第三大企业集团,在能源,ICT和生命科学等多个行业拥有100多家分支机构。任职SK公司之前,他曾任职SunTrust Robinson Humphrey公司,在那里他曾建议许多上市工业公司的并购和资本市场交易。加入SunTrust之前,他曾任职Progress Partners公司(专注于媒体和技术的投资银行公司),在那里他曾为早期到中期阶段的客户执行并购和融资项目,并管理Progress Ventures公司(其附属风险资本部门)的三个投资基金。李先生在汉阳大学获得学士学位,在康奈尔大学获得工商管理硕士学位。
Sungsik Lee has been our President since our inception. Most recently, Mr. Lee led cross-border M&A and strategic investments across the broad sustainability-focused areas at the Global Development Group of SK, the third-largest conglomerate in Korea with more than 100 affiliates over diverse sectors including energy, ICT, and life sciences. Prior to SK, Mr. Lee was at SunTrust Robinson Humphrey, where he advised many publicly traded industrial companies on M&A and capital market transactions. Before joining SunTrust, Mr. Lee was at Progress Partners, a media and technology-focused investment banking firm, where he executed M&A and financing projects for early-to-mid-stage clients and managed three investment funds at Progress Ventures, its affiliated venture capital arm. Mr. Lee received his B.A. from Hanyang University and M.B.A. from Cornell University.
Gene Young Cho

Gene Young Cho自公司成立以来一直是我们的首席运营官。Gene Young Cho博士带来了商业运营和生命科学方面的领导能力和经验。目前,他是CG Pharmaceuticals,Inc.(CrystalGenomics的美国子公司)的执行董事。在这个职位上,Cho博士专注于发展增长战略,以及提供CG Pharmaceuticals的运营和扩展的战略规划和管理。此前,Cho博士曾在L.E.K.Consulting担任生命科学顾问,与生物制药,合同服务,医疗设备,医疗保健服务,HCIT,数字健康和AI领域的客户合作。他的一些具体经验包括在领先的生物制药或医疗保健服务公司的大规模并购交易中工作,为收购目标识别提供支持,实施管道开发战略,以及优化快速增长的生物技术公司的治理结构。他还通过专注于支持新兴技术和初创企业的专业网络,在亚洲市场带来了丰富的经验。Cho博士在加州大学伯克利分校获得生物工程学士学位,在纽约大学医学院获得生物医学成像博士学位,并在Memorial Sloan Kettering完成博士后研究,专注于乳腺癌成像。Cho博士在担任研究员期间,还在期刊上发表了10多篇文章,并发表了几篇会议摘要。他是我们的董事候选人Joong Myung Cho博士的儿子。


Gene Young Cho has been our Chief Operating Officer since our inception. Currently, he is the Executive Director of CG Pharmaceuticals, Inc., the U.S. subsidiary of CrystalGenomics. In this role, Dr. Cho is focused on developing growth strategies as well as providing strategic planning and management of the operations and expansion of CG Pharmaceuticals. Previously, Dr. Cho worked as a life sciences consultant at L.E.K. Consulting, working with clients in biopharmaceuticals, contract services, medical devices, healthcare services, HCIT, digital health, and AI. Some of his specific experiences include working on large-scale M&A transactions of leading biopharmaceuticals or healthcare service companies, supporting target identification for acquisition, implementing pipeline development strategies, and optimizing governance structures of fast-growing biotech companies. Dr. Cho received his B.S. in bioengineering at U.C. Berkeley, Ph.D. from the NYU School of Medicine in biomedical imaging and completed his post-doc at Memorial Sloan Kettering focusing on breast cancer imaging. Dr. Cho is also the author of over 10 publications in journals and several conference abstracts during his time as a researcher. He is the son of our director nominee, Dr. Joong Myung Cho.
Gene Young Cho自公司成立以来一直是我们的首席运营官。Gene Young Cho博士带来了商业运营和生命科学方面的领导能力和经验。目前,他是CG Pharmaceuticals,Inc.(CrystalGenomics的美国子公司)的执行董事。在这个职位上,Cho博士专注于发展增长战略,以及提供CG Pharmaceuticals的运营和扩展的战略规划和管理。此前,Cho博士曾在L.E.K.Consulting担任生命科学顾问,与生物制药,合同服务,医疗设备,医疗保健服务,HCIT,数字健康和AI领域的客户合作。他的一些具体经验包括在领先的生物制药或医疗保健服务公司的大规模并购交易中工作,为收购目标识别提供支持,实施管道开发战略,以及优化快速增长的生物技术公司的治理结构。他还通过专注于支持新兴技术和初创企业的专业网络,在亚洲市场带来了丰富的经验。Cho博士在加州大学伯克利分校获得生物工程学士学位,在纽约大学医学院获得生物医学成像博士学位,并在Memorial Sloan Kettering完成博士后研究,专注于乳腺癌成像。Cho博士在担任研究员期间,还在期刊上发表了10多篇文章,并发表了几篇会议摘要。他是我们的董事候选人Joong Myung Cho博士的儿子。
Gene Young Cho has been our Chief Operating Officer since our inception. Currently, he is the Executive Director of CG Pharmaceuticals, Inc., the U.S. subsidiary of CrystalGenomics. In this role, Dr. Cho is focused on developing growth strategies as well as providing strategic planning and management of the operations and expansion of CG Pharmaceuticals. Previously, Dr. Cho worked as a life sciences consultant at L.E.K. Consulting, working with clients in biopharmaceuticals, contract services, medical devices, healthcare services, HCIT, digital health, and AI. Some of his specific experiences include working on large-scale M&A transactions of leading biopharmaceuticals or healthcare service companies, supporting target identification for acquisition, implementing pipeline development strategies, and optimizing governance structures of fast-growing biotech companies. Dr. Cho received his B.S. in bioengineering at U.C. Berkeley, Ph.D. from the NYU School of Medicine in biomedical imaging and completed his post-doc at Memorial Sloan Kettering focusing on breast cancer imaging. Dr. Cho is also the author of over 10 publications in journals and several conference abstracts during his time as a researcher. He is the son of our director nominee, Dr. Joong Myung Cho.